Search company, investor...
Chromatin company logo


Founded Year



Unattributed | Dead

Total Raised


Last Raised


About Chromatin

Chromatin develops and sells hybrid sorghum planting seed to growers and producers around the world who are attracted to sorghum's rapid maturation, tolerance to heat, cold and drought and high yields.

Headquarters Location

10 S LaSalle Street Suite 2100

Chicago, Illinois, 60603,

United States


Missing: Chromatin's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Chromatin's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Chromatin Patents

Chromatin has filed 18 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • Genetic engineering
  • Genetics
patents chart

Application Date

Grant Date


Related Topics




Biotechnology, Molecular biology, Plant physiology, Cell biology, Genetic engineering


Application Date


Grant Date



Related Topics

Biotechnology, Molecular biology, Plant physiology, Cell biology, Genetic engineering



Latest Chromatin News

Chromatin Immunoprecipitation Sequencing Market Size 2022 Global Key Findings, Industry Demand, Regional Analysis, Key Players Profiles, Future Prospects and Forecasts to 2028

Feb 4, 2022

Search jobs 04-Feb-2022 Chromatin Immunoprecipitation Sequencing Market Size 2022 Global Key Findings, Industry Demand, Regional Analysis, Key Players Profiles, Future Prospects and Forecasts to 2028 Chromatin Immunoprecipitation Sequencing or ChIP-seq is a method which is used to detect the interaction between DNA and Protein using next generation sequencing. It combines the chromatin immunoprecipitation with DNA sequencing for the identification of the binding sites of DNA-associated proteins. It is a type of tool that helps in determining the location of the DNA binding sites on the genome for a protein of interest. Chromatin Immunoprecipitation sequencing helps the researcher for the screening and identification of the protein binding sites on the complete chromosomal scale with high and improved accuracy and efficiency. Chromatin Immunoprecipitation Sequencing Market: Drivers and Restraints Rising incidence of immunology cases which required to test antigen-antibody interaction is a vital factor which positively influencing the growth of the market. Government has taken several initiatives and increases fund to promote the research conducted on combining chromatin immunoprecipitation and next generation DNA sequencing is also driving the market. The Chromatin Immunoprecipitation Sequencing is also useful for early detection of metabolic and obesity-related disorders. This is expected to fuelling the chromatin immunoprecipitation sequencing market during the forecast period. Although few factors such as cellular composition of the tissue, frozen sample availability, high lipid content can restrain the concern market. Request a sample to obtain authentic analysis and comprehensive market insights at- Chromatin Immunoprecipitation Sequencing Market: Overview Global Chromatin Immunoprecipitation Sequencing market has witnessed growth due to expanding demand for Immunoprecipitation testing for various diseases like cancer and certain cardiovascular conditions. Chromatin Immunoprecipitation Sequencing is preferred over ChIP-on-chip. The DNA fragments while the Immunoprecipitation are isolated and can be identified by various methods like, DNA microarray, PCR and DNA sequencing. Combining NGS with ChIP, is also expected to contribute to boost the demand for Chromatin Immunoprecipitation Sequencing. Chromatin Immunoprecipitation Sequencing Market: Key Market Participants Some of the market participants in the Global Chromatin Immunoprecipitation Sequencing market identified across the value chain include: Creative Diagnostics, Profacgen, Merck KGaA, Bio-Techne, Abcam plc, Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., BioLegend, Inc., Active Motif, and Thermo Fisher Scientific Inc. The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry. Discover more about report analysis with figures and data tables, along with the table of contents. Request for TOC- Chromatin Immunoprecipitation Sequencing Market: Segmentation To gain a comprehensive and a better understanding of the future market equity, the market report is segmented based on product type, application, end user and region. Based on the product type Chromatin Immunoprecipitation Sequencing is segmented into: Chromatin Immunoprecipitation Sequencing Kits Cardiovascular Diseases Research Institutes North- America

Chromatin Frequently Asked Questions (FAQ)

  • When was Chromatin founded?

    Chromatin was founded in 2000.

  • Where is Chromatin's headquarters?

    Chromatin's headquarters is located at 10 S LaSalle Street, Chicago.

  • What is Chromatin's latest funding round?

    Chromatin's latest funding round is Unattributed.

  • How much did Chromatin raise?

    Chromatin raised a total of $131.08M.

  • Who are the investors of Chromatin?

    Investors of Chromatin include BP Alternative Energy Ventures, Wood Creek Capital Management, PrivateBancorp, Venture Investors, IllinoisVENTURES and 21 more.

  • Who are Chromatin's competitors?

    Competitors of Chromatin include Acumen Pharmaceuticals, Indigo Ag, Aphios, Open Monoclonal Technology, Arcadia Biosciences and 11 more.

Compare Chromatin to Competitors

Stine Seed Logo
Stine Seed

Stine Seed is an independent seed company dedicated to serving farmer customers with support from its team of agronomists and district and regional managers.

SemBioSys Genetics

SemBioSys Genetics Inc is a biotechnology company focused on the development commercialization and production of protein-based pharmaceuticals and nonpharmaceutical products based on our plant genetic engineering skills and our proprietary oilbodyoleosin technology platform, the Stratosome Biologic System

Integrated Plant Genetics

Integrated Plant Genetics, Inc. is a development stage biotechnology company, in business to produce and license genes and technologies for the purposes of microbial, horticultural, agricultural and forest tree improvement, including pathogen control. IPG aims to provide contract genetic engineering services, advanced plant breeding technologies for freedom to operate in creating transgenic crops, and assistance in developing regulatory data submission packages. IPG offers environmentally sound and sustainable alternatives to costly and often toxic chemical pest control methods. IPG is a Florida-grown company, with strong ties to the University of Florida, and a commitment to Florida agriculture.

Agrisoma BioSciences

Agrisoma Biosciences is an agricultural company that has commercialized carinata, a non-food oilseed crop designed for sustainable production of biofuels. Agrisoma sells carinata seed products under the Resonance brand name, and uses advanced crop improvement technologies to provide superior crop varieties to growers.

Agrivida Logo

Agrivida is an agricultural biotechnology company developing energy crops designed to produce chemicals, fuels, and bioproducts from non-food cellulosic biomass. The company's approach is designed to provide an integrated solution for delivering the lowest-cost sugars that are essential for industrial bioproducts. The basis of Agrivida's integrated solution is engineering the feedstock to contain cell wall-degrading enzymes, and other valuable traits, which are activated following harvest. Agrivida plans to commercialize its platform through alliances across the bioindustrial product supply chain.


Respirics Inc. is a pulmonary drug delivery and development company located in Raleigh, North Carolina. The company is developing a line of branded inhalation drug products in its patented Acu-Breathe™ dry powder inhalers, and is working with pharmaceutical clients to enhance the delivery of their own compounds or formulations. Respirics combines proprietary inhalation technology with powder drug formulation expertise to develop unique drug delivery solutions. The company is committed to bringing effective, easy-to-use and affordable inhalation drug products to the patients who need them.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.